Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from http://www.ncbi.nlm.nih.gov/pubmed/31701290 below:

Impact of microscopically margin-positive resection on survival in children with hepatoblastoma after hepatectomy: a retrospective cohort study

Affiliations

• ¹ Graduate School of Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100730, People's Republic of China.
• ² Department of Pediatric Surgery, Capital Institute of Pediatrics, No. 2 Yabao Road, Chaoyang District, Beijing, People's Republic of China.
• ³ Graduate School of Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100730, People's Republic of China. lilong3@hotmail.com.
• ⁴ Department of Pediatric Surgery, Capital Institute of Pediatrics, No. 2 Yabao Road, Chaoyang District, Beijing, People's Republic of China. lilong3@hotmail.com.

• PMID: 31701290
• DOI: 10.1007/s10147-019-01573-0

Item in Clipboard

Xianghai Ren et al. Int J Clin Oncol. 2020 Apr.

• ¹ Graduate School of Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100730, People's Republic of China.
• ² Department of Pediatric Surgery, Capital Institute of Pediatrics, No. 2 Yabao Road, Chaoyang District, Beijing, People's Republic of China.
• ³ Graduate School of Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100730, People's Republic of China. lilong3@hotmail.com.
• ⁴ Department of Pediatric Surgery, Capital Institute of Pediatrics, No. 2 Yabao Road, Chaoyang District, Beijing, People's Republic of China. lilong3@hotmail.com.

• PMID: 31701290
• DOI: 10.1007/s10147-019-01573-0

Item in Clipboard

Background: Impact of R1 (microscopically margin-positive) resection on survival of patients with hepatoblastoma (HB) remains debatable. This study aimed to compare the long-term outcomes of R0 (microscopically margin-negative) and R1 resection for HB in children after hepatectomy.

Methods: We retrospectively reviewed files of children with HB who underwent resection at our institution between September 1, 2005, and November 30, 2017. Survival analyses and prognostic factors were evaluated using Kaplan-Meier curves and Cox regression models.

Results: Of 259 patients, 218 (84.2%) underwent R0 and 41 (15.8%) R1 resection. After adjusting for confounding factors, R1 resection demonstrated non-significantly lower overall survival (OS: hazard ratio [HR] = 0.75; 95% CI 0.34-1.64) and shorter event-free survival (EFS: HR = 0.97; 95% CI 0.53-1.78) rates than R0 resection. However, stratified analysis showed significantly increased risk of poor OS and EFS in patients with metastasis and mixed epithelial/mesenchymal pathologic subtype in R1 compared with R0 resection (P values for interactions < 0.05). There was no significant difference between R0 resection with metastasis and R1 resection with metastasis in the incidence of local recurrence (P = 0.494); however, a significant difference in the incidence of local recurrence was seen between R0 and R1 resection for subgroups with mixed pathologic subtypes (P = 0.035).

Conclusions: With effective chemotherapy, microscopic margin status may not be associated with survival outcome in children with HB undergoing hepatectomy. However, stratified analysis showed that R1 resection might be associated with decreased survival in children with mixed epithelial/mesenchymal HB, compared with R0 resection, and not affect survival outcomes in those with an epithelial subtype and without metastasis.

Keywords: Hepatectomy; Hepatoblastoma; Metastasis; Positive surgical margins; Survival rate.

PubMed Disclaimer

• Microscopically positive resection margin after hepatoblastoma resection: what is the impact on prognosis? A Childhood Liver Tumours Strategy Group (SIOPEL) report.

  Aronson DC, Weeda VB, Maibach R, Czauderna P, Dall'Igna P, de Ville de Goyet J, Branchereau S, Perilongo G, Brock P, Zsiros J, Semeraro M, Chardot C, Wildhaber B, Morland B, Brugières L; Childhood Liver Tumour Strategy Group (SIOPEL). Aronson DC, et al. Eur J Cancer. 2019 Jan;106:126-132. doi: 10.1016/j.ejca.2018.10.013. Epub 2018 Dec 5. Eur J Cancer. 2019. PMID: 30528797

• Repeat hepatectomy for pediatric recurrent chemotherapy-resistant hepatoblastoma: a report of 18 cases.

  Li X, Wang Z, Zhang D, Zhao D, Ye J, Duan W, Duan L, Liu Q. Li X, et al. J Cancer Res Clin Oncol. 2023 Jul;149(7):4015-4023. doi: 10.1007/s00432-022-04291-9. Epub 2022 Aug 29. J Cancer Res Clin Oncol. 2023. PMID: 36038674

• Pure fetal histology subtype was associated with better prognosis of children with hepatoblastoma: A Chinese population-based study.

  Qiao GL, Chen Z, Wang C, Ge J, Zhang Z, Li L, Ren J. Qiao GL, et al. J Gastroenterol Hepatol. 2016 Mar;31(3):621-7. doi: 10.1111/jgh.13165. J Gastroenterol Hepatol. 2016. PMID: 26401976

• Negative surgical margin improved long-term survival of colorectal cancer liver metastases after hepatic resection: a systematic review and meta-analysis.

  Liu W, Sun Y, Zhang L, Xing BC. Liu W, et al. Int J Colorectal Dis. 2015 Oct;30(10):1365-73. doi: 10.1007/s00384-015-2323-6. Epub 2015 Jul 23. Int J Colorectal Dis. 2015. PMID: 26198997 Review.

• Outcome and complications after resection of hepatoblastoma.

  Towu E, Kiely E, Pierro A, Spitz L. Towu E, et al. J Pediatr Surg. 2004 Feb;39(2):199-202; discussion 199-202. doi: 10.1016/j.jpedsurg.2003.10.013. J Pediatr Surg. 2004. PMID: 14966740 Review.

• Surgical Strategy for Pediatric Liver Tumors Involving the Hepatic Venous Confluence and the Inferior Vena Cava.

  Fuchs J, Rabaux-Eygasier L, Hery G, Fouquet V, Guerin F, Franchi-Abella S, Branchereau S. Fuchs J, et al. Ann Surg Oncol. 2025 Mar 26. doi: 10.1245/s10434-025-17245-5. Online ahead of print. Ann Surg Oncol. 2025. PMID: 40138145

• Management for patients with pediatric surgical disease during the COVID-19 epidemic.

  Zhou Y, Xu H, Li L, Ren X. Zhou Y, et al. Pediatr Surg Int. 2020 Jun;36(6):751-752. doi: 10.1007/s00383-020-04656-6. Epub 2020 Apr 20. Pediatr Surg Int. 2020. PMID: 32307559 Free PMC article. No abstract available.

• A narrative review of the challenges and countermeasures in hepatoblastoma management during COVID-19 epidemic.

  Xu H, Zhou Y, Sun R, Liu X, Diao M, Ren X, Li L. Xu H, et al. Transl Pediatr. 2020 Dec;9(6):840-848. doi: 10.21037/tp-20-143. Transl Pediatr. 2020. PMID: 33457307 Free PMC article. Review.

• Advances in the conventional clinical treatment for hepatoblastoma and therapeutic innovation.

  Chen Z, Dong R. Chen Z, et al. World J Pediatr Surg. 2021 Jun 8;4(3):e000220. doi: 10.1136/wjps-2020-000220. eCollection 2021. World J Pediatr Surg. 2021. PMID: 36474976 Free PMC article. Review.

• The challenges in colorectal cancer management during COVID-19 epidemic.

  Ren X, Chen B, Hong Y, Liu W, Jiang Q, Yang J, Qian Q, Jiang C. Ren X, et al. Ann Transl Med. 2020 Apr;8(7):498. doi: 10.21037/atm.2020.03.158. Ann Transl Med. 2020. PMID: 32395542 Free PMC article. Review.

1. 1. Cancer. 2011 May 1;117(9):1976-83 - PubMed
2. 1. J Pediatr Surg. 2019 May;54(5):1035-1040 - PubMed
3. 1. Pediatr Radiol. 2007 Feb;37(2):123-32; quiz 249-50 - PubMed
4. 1. J Pediatr Surg. 2012 Dec;47(12):2194-8 - PubMed
5. 1. Ann Surg. 2008 Oct;248(4):626-37 - PubMed

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3